IRIS
PUGLISI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.474
AS - Asia 12.009
EU - Europa 7.003
SA - Sud America 2.180
Continente sconosciuto - Info sul continente non disponibili 1.372
AF - Africa 270
OC - Oceania 16
Totale 49.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.978
SG - Singapore 5.756
CN - Cina 2.297
BR - Brasile 1.719
IT - Italia 1.461
UA - Ucraina 1.278
HK - Hong Kong 1.176
VN - Vietnam 1.062
DE - Germania 952
RU - Federazione Russa 592
FI - Finlandia 581
FR - Francia 513
SE - Svezia 355
IN - India 351
BD - Bangladesh 344
GB - Regno Unito 324
IE - Irlanda 318
CA - Canada 268
TR - Turchia 201
AR - Argentina 154
KR - Corea 149
NL - Olanda 100
MX - Messico 96
PL - Polonia 88
JP - Giappone 85
AT - Austria 83
ID - Indonesia 76
IQ - Iraq 76
EC - Ecuador 74
CO - Colombia 70
ZA - Sudafrica 67
ES - Italia 60
BE - Belgio 59
PK - Pakistan 57
VE - Venezuela 53
CZ - Repubblica Ceca 44
SA - Arabia Saudita 42
CH - Svizzera 39
JM - Giamaica 35
MA - Marocco 34
UZ - Uzbekistan 34
RO - Romania 32
AE - Emirati Arabi Uniti 31
IR - Iran 31
CL - Cile 30
TG - Togo 30
PY - Paraguay 27
PH - Filippine 25
TN - Tunisia 24
LT - Lituania 22
PE - Perù 22
KE - Kenya 21
EG - Egitto 20
NP - Nepal 20
DZ - Algeria 19
UY - Uruguay 19
TH - Thailandia 18
MY - Malesia 17
EU - Europa 16
GR - Grecia 16
IL - Israele 15
OM - Oman 15
AU - Australia 14
CR - Costa Rica 14
KZ - Kazakistan 13
AL - Albania 12
AZ - Azerbaigian 12
BO - Bolivia 12
HN - Honduras 12
JO - Giordania 12
LB - Libano 11
TT - Trinidad e Tobago 11
KG - Kirghizistan 10
AM - Armenia 9
EE - Estonia 9
ET - Etiopia 9
LV - Lettonia 9
NI - Nicaragua 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
BG - Bulgaria 7
BY - Bielorussia 7
GT - Guatemala 7
PA - Panama 7
RS - Serbia 7
TW - Taiwan 7
LA - Repubblica Popolare Democratica del Laos 6
SV - El Salvador 6
BB - Barbados 5
BH - Bahrain 5
CI - Costa d'Avorio 5
DK - Danimarca 5
KH - Cambogia 5
MD - Moldavia 5
MN - Mongolia 5
QA - Qatar 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
HR - Croazia 4
Totale 47.878
Salva come PNG Salva come JPEG
Città #
Fairfield 2.563
Ashburn 2.506
Singapore 2.342
Woodbridge 1.762
Houston 1.294
San Jose 1.246
Hong Kong 1.164
Chandler 1.120
Council Bluffs 1.024
Seattle 1.017
Ann Arbor 1.010
Beijing 978
Wilmington 933
Cambridge 855
Jacksonville 821
Boardman 557
Los Angeles 551
Dearborn 548
Chicago 476
Lauterbourg 384
Ho Chi Minh City 326
Dublin 309
Princeton 299
New York 283
Santa Clara 243
Dallas 222
Hanoi 216
Buffalo 209
Udine 192
Hefei 186
Salt Lake City 175
Milan 168
Helsinki 165
São Paulo 159
Munich 158
Phoenix 149
Dong Ket 145
San Diego 145
The Dalles 144
Redondo Beach 136
Seoul 133
Izmir 126
Elk Grove Village 94
Tampa 92
Ogden 86
Des Moines 85
Frankfurt am Main 84
Tokyo 80
Nuremberg 78
Rome 75
Warsaw 74
Montreal 70
Brooklyn 68
Orem 64
Denver 56
Ottawa 55
Miami 54
Brussels 53
Lancaster 52
London 51
Norwalk 51
Guangzhou 50
Turku 47
Stockholm 46
Chennai 45
Mumbai 45
Nanjing 45
Washington 45
Atlanta 44
Sterling 44
Trieste 43
Kunming 42
Toronto 42
Mexico City 40
Rio de Janeiro 39
Baghdad 38
Belo Horizonte 38
Poplar 38
San Francisco 38
Amsterdam 37
Da Nang 37
Codroipo 36
Johannesburg 36
Detroit 34
Lappeenranta 34
Vienna 34
Manchester 33
Shanghai 33
Boston 31
Naples 31
Curitiba 30
Lomé 30
Tashkent 30
Brasília 29
Brno 29
Redmond 29
Hyderabad 28
Newark 28
Paris 28
Zurich 28
Totale 30.195
Salva come PNG Salva come JPEG
Nome #
Risks in Oncology and Radiation Therapy 689
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 688
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 483
Hepatitis B and cancer: A practical guide for the oncologist 271
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 235
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis 230
Bone scanning in lung cancer [2] (multiple letters) 230
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 225
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects 223
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? 213
Expression of periostin in human breast cancer 211
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value 210
Role of pre-surgical breast MRI in the management of invasive breast carcinoma 208
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis 202
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 198
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma 198
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 197
Pattern of metastasis and outcome in patients with breast cancer 196
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme 194
Galectin-3 expression in non-small cell lung carcinoma 191
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 189
Bevacizumab in older patients with advanced colorectal or breast cancer 188
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 188
Role of mammography, ultrasound and large-core biopsy in the diagnostic evaluation of papillary breast lesions 187
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 187
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 185
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer 185
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 184
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 182
Molecular diagnosis of neoplasms 181
B-cell lymphoma presenting as acute pancreatitis 179
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme 178
Bone scanning in lung cancer: pretest probability is of value 177
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer 177
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 175
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. 175
Measures of outcome in metastatic breast cancer: insights from a real-world scenario. 175
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 175
D-dimer and venous thromboembolism 174
Gene expression profiling in breast cancer: a clinical perspective. 174
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. 174
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 172
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy 172
Primary therapy in breast cancer: what have we learned from landmark trials? 171
Taxane-induced nail changes: incidence, clinical presentation and outcome 170
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example 169
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 168
What does similarity mean in clinical trials? 167
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) 167
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics 166
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy 166
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY 166
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients 163
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer 162
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 162
TSH controls ref-1 nuclear translocation in thyroid cells 161
Treatment of metastatic breast cancer in a real-world scenario: Is progression-free survival with first line predictive of benefit from second and later lines? 161
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer 161
Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway 160
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma 160
Prognostic evaluation in palliative care: final results from a prospective cohort study 160
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? 160
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 158
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?] 158
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly 158
Do platinum salts fit all triple negative breast cancers? 158
Angiogenesis and tumor growth 156
Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study 156
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 156
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 156
Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology 155
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. 155
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 155
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 154
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 154
p53 protein expression and p53 mutation in thymic epithelial tumors 153
Expert pathology consultation through the Internet: melanoma versus benign melanocytic tumours 153
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients 153
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS 153
Looking for predictive markers in breast cancer 153
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 153
Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas 152
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 152
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial 151
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? 151
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index 150
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart? 150
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 150
Atypical ductal hyperplasia of the breast. Its diagnostic imaging and the role of percutaneous needle biopsy with a 14-gauge needle 149
Treatment of HER2-positive breast cancer: current status and future perspectives 149
Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma. 149
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) 149
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 149
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 148
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. 147
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole 147
CDK 4/6 inhibitors as single agent in advanced solid tumors 147
Sequential chemotherapy with Paclitaxel plus Cisplatin, followed by Vinorelbine, followed by Gemcitabine in advanced non-small cell lung cancer: an Alpe Adria Thoracic Oncology Multidisciplinary group study (ATOM 001) 146
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report 145
First-line chemotherapy with or without biologic agents for metastatic breast cancer 144
Totale 18.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.125 0 0 83 162 69 142 148 116 40 440 551 374
2022/20232.662 332 191 71 309 270 726 29 205 338 37 90 64
2023/20241.387 123 91 73 51 194 277 41 74 134 109 59 161
2024/20257.555 190 466 304 251 377 416 470 430 768 706 1.191 1.986
2025/202617.102 1.641 2.326 1.454 1.607 2.241 1.204 1.746 607 1.143 1.263 1.174 696
2026/20272.504 549 1.365 590 0 0 0 0 0 0 0 0 0
Totale 49.324